The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Oncologic outcomes in patients with residual invasive upper tract urothelial carcinoma following neoadjuvant chemotherapy.
 
Sean A. Fletcher
No Relationships to Disclose
 
Maximilian Pallauf
No Relationships to Disclose
 
Emelia K. Watts
No Relationships to Disclose
 
Kara A. Lombardo
No Relationships to Disclose
 
Jack A. Campbell
No Relationships to Disclose
 
Andrea Mari
No Relationships to Disclose
 
Morgan Rouprêt
No Relationships to Disclose
 
Stephen A. Boorjian
Consulting or Advisory Role - ArTara Therapeutics; FerGene; Ferring; Prokarium
 
Hooman Djaladat
No Relationships to Disclose
 
Eiji Kikuchi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb-Ono Pharmaceutical; Chugai Pharma; Janssen; Merck/Pfizer; MSD
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb-Ono Pharmaceutical; Chugai Pharma; Janssen; Kissei Pharmaceutical; Kyorin; Kyowa Kirin International; Merck; MSD; Nippon Kayaku; Nippon Shinyaku; Pfizer; Sanofi; Taiho Pharmaceutical; Takeda
Research Funding - Chugai Pharma (Inst); Kissei Pharmaceutical (Inst); Kyorin (Inst); Kyowa Kirin International (Inst); Nihonkayaku (Inst); Nippon Shinyaku (Inst); Otsuka (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Francesco Soria
No Relationships to Disclose
 
Michael Rink
No Relationships to Disclose
 
Jay D. Raman
No Relationships to Disclose
 
Firas Abdollah
Consulting or Advisory Role - Decipher Biosciences
 
Guillaume Ploussard
No Relationships to Disclose
 
Jean H. Hoffman-Censits
Honoraria - Clovis Oncology; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Foundation medicine; Roche/Genentech; Seagen
Research Funding - Foundation Medicine; Genentech; Genentech; Sanofi
Travel, Accommodations, Expenses - Roche/Genentech
 
David James McConkey
No Relationships to Disclose
 
Shahrokh F. Shariat
Stock and Other Ownership Interests - Seagen; Urogen pharma
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Dr. August Wolff GmbH & Co. KG Arzneimittel; Ferring; Ipsen; Janssen; MSD; Olympus; Pfizer; Pierre Fabre; Roche; Sanochemia; Sanofi; Urogen pharma
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Speakers' Bureau - Astellas Pharma; Bayer; Bristol-Myers Squibb; Cepheid; Ferring; Ipsen; Janssen; Lilly; MSD; Olympus; Pfizer; Pierre Fabre; Ribon Therapeutics; Roche; Sanochemia; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent US07759077; Patent US20030054419; Patent US20030235816; Patent US2003235816
 
Benjamin Pradere
No Relationships to Disclose
 
Nirmish Singla
No Relationships to Disclose